Next-generation sequencing (NGS) services refer to non-Sanger-based high-throughput DNA sequencing services. These services involves performing DNA or RNA sequencing using the latest technology such as sequencing $synthesis, ion semiconductor sequencing, single-molecule real-time sequencing and nanopore sequencing, to provide reliable results and high-quality sequencing data with accurate gene-expression-level estimations to the customers. NGS services include whole-genome sequencing, targeted re-sequencing, RNA-Seq, De novo sequencing, exome sequencing, Chip-Seq, and Methyl-Seq, among others. "
Visionary leaders are the leading market players in terms of new developments such as product launches, innovative technologies, and the adoption of growth strategies. These players have a broad product offering that caters to most of the regions globally. Visionary leaders primarily focus on acquiring the leading market position through their strong financial capabilities and their well-established brand equity.
Dynamic Differentiators are established players with very strong business strategies. However, they have a weaker product portfolio compared to the visionary leaders. They generally focus only on a specific type of technology related to the product.
Innovators in the competitive leadership mapping are vendors that have demonstrated substantial product innovations as compared to their competitors. The companies have focused on product portfolios. However, they do not have very strong growth strategies for their overall business, when compared with the visionary leaders.
Emerging companies have niche product and service offerings. Their business strategies are not as strong as that of the established vendors. The emerging vendors include the new entrants in the market, emerging in terms of product portfolio and geographic reach, and require time to gain significant traction in the market.
Best Next-Generation Sequencing (NGS) Services
- Enterprise
- SME
- Startups
NGS refers to non-Sanger-based, high-throughput DNA sequencing technologies. DNA strands can be sequenced simultaneously, yielding substantially more throughput and minimizing the need for fragment-cloning methods that are often used in the Sanger sequencing of genomes.
The next-generation sequencing (NGS) market is expected to grow to USD 24 billion by 2025. Advancements in NGS technologies have reduced the costs of sequencing platforms and systems as well as the sequencing process itself. This is one of the major drivers for the growth of the NGS market. The regulatory and reimbursement outlook for NGS has improved considerably in recent years, which also serves to boost the adoption of sequencing technologies among a wider user base.
Drivers, Restrains, Opportunities & Challenges in the Next-Generation Sequencing Market.
This report identifies and benchmarks the key market players in the Next-Generation Sequencing market such as Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Next-Generation Sequencing ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies.
The report includes market specific company profiles of all 20 players and assesses the recent developments that shape the competitive landscape of this highly fragmented market.
This report identifies and benchmarks the key market players in the Next-Generation Sequencing market such as Illumina, Inc. (US), Thermo Fisher Scientific, Inc. (US), BGI Group (China), PerkinElmer Inc. (US), Macrogen (South Korea), and evaluates them on the basis of business strategy excellence and strength of product portfolio within the Next-Generation Sequencing ecosystem, combining inputs from various industry experts, buyers, and vendors, and extensive secondary research including annual reports, company press releases, investor presentations, free and paid company databases. They are rated and positioned on 2x2 matrix, called as ‘Company Evaluation Quadrant’, and identified as Visionary Leaders, Dynamic Differentiators, Innovators, or Emerging companies.
SAMPLES:
- Updated version of this Quadrant
- Different Company Evaluation Quadrant
- 'Startup Only' Company Evaluation Quadrant
- Region or Country specific evaluation
- Application or Industry specific evaluation ..Read More
- Submit a Briefing Request
- Question about our published research
- Request for evaluation of your organization for specific market
- Request for re-evaluation of Company Evaluation Quadrant ..Read More